This episode currently has no reviews.
Submit ReviewAmericans will soon have access to several new COVID-19 vaccines. The FDA is expected to finally approve Pfizer and Moderna vaccines for children under 5 as well as the protein-based Novavax vaccine. Looking ahead, the FDA is meeting in late June to discuss a vaccine targeting multiple variants of the virus, which may be available in the fall. How do all these shots compare to our current ones, and how do you know what’s right for your family? Andy gets answers from epidemiologist Katelyn Jetelina and New York Times health reporter Apoorva Mandavilli.
Keep up with Andy on Twitter @ASlavitt.
Follow Katelyn Jetelina and Apoorva Mandavilli on Twitter @dr_kkjetelina and @apoorva_nyc.
Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.
Support the show by checking out our sponsors!
Check out these resources from today’s episode:
Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.
For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.
See omnystudio.com/listener for privacy information.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review